September 30th 2024
The event will focus on innovating with cutting-edge technology, featuring the likes of pharmaceutical technology companies revolutionizing the industry.
August 18th 2024
To scale up diabetes intervention programs, sustainable workflows, trainings, and payment models are key.
August 17th 2024
Sustainable pharmacy partnerships require addressing financial, technology, and customer needs.
June 24th 2024
The can’t-miss event on July 13 features speakers and CE sessions focused on streamlining pharmacy finances and services.
April 1st 2024
The can’t-miss event on April 13 features speakers and CE sessions focused on elevating patient-centric care.
CDC creates standard for sharing infection data
The CDC is developing a standards-based solution for sharing healthcare-associated infection data
Anticoagulate for at least one year after drug-eluting stent is put in
PCI guideline update recommends long-term anticoagulation for DES
Drug Topics survey finds R.Ph.s approve of BTC class of drugs
Drug Topics poll: R.Ph.s favor BTC class of drugs
PTCB mulling new plans for technicians
The Pharmacy Technician Certification Board is considering offering a new certification program in IV admixture as well as continuous testing
Orphan drug under study to be available to more patients
Gentium expands access to defibrotide under compassionate use basis
DEA suspends second Cardinal DC
The Drug Enforcement Administration has suspended the license at a second Cardinal Health distribution facility located in Lakeland, Fla.
Longs Drugs to open first walk-in medical clinic in Hawaii
Longs Drugs to open walk-in medical clinic in Hawaii
CRN calls for transparency in testing dietary supplements
CRN responds to Informed-Choice report calling for transparency in testing dietary supplements
An interview with Larry Kocot: Lessons from CMS
An interview with Larry Kocot, who is now at Brookings Institution. Kocot was formerly with the Centers for Medicare and Medicaid.
This breast cancer drug is first in new class of chemo agents
The FDA has approved Ixabepilone (Ixempra) as a monotherapy and in combination with capecitabine (Xeloda) for patients with metastic or locally advanced breast cancer.
Beneficiary participation in MTM services
While there still is a great deal of variation in the MTM programs for 2007, pharmacist involvement has increased relative to the degree of pharmacist involvement in 2006.
Many pharmacies not ready for DMEPOS accreditation
Pharmacies that sell DMEPOS supplies to Medicare patients face a variety of options for accreditation.
Report: Networked medical sensors to aid millions of seniors by 2012
More than three million seniors will benefit from networked medical sensors at home in 2012.
HHS panel focuses on medical errors
Agency for Healthcare Research and Quality releases new tools to help reduce medical errors
White Paper out on managing Rx hazardous waste in hospitals
White paper focuses on managing hazardous pharmaceutical waste in hospitals
Two new guides summarize efficacy and safety of diabetes meds
New guides outline latest evidence on Type 2 diabetes medications
FDA's stand on compounding is bad for R.Ph.s and patients
A compounding leader takes issue with FDA's position that compounding is the production of a new drug that needs to be approved.
New products: December 10, 2007
The new products include branded drugs, new formulations, new indications, and new dosing, along with OTCs and home health and beauty items.
Will holiday 2007 sales be lean or green?
Pharmacy chains are expecting a bright holiday sales season for 2007.
Manufacturers are putting a new spin on OTCs
New over-the-counter formulations
FAIR OR FOUL?
Among the questions asked were what is expected for sales, salaries, and staffing for 2008.
In the pipeline: Keeping an eye on the AMD market
New drugs in development for age-related macular degeneration (AMD).
150 Years of American Pharmacy: Stirring up interest in Christmas
Christmas slows rises in importance for pharmacies during the 20th century.
Pharmacy professor bridges the Alzheimer's divide
Patience and cooperation have been the hallmarks of an award-winning career in Alzheimer's care for pharmacist Robert Cluxton.
Letters to the editor: December 10, 2007
Lost in translation: Immigrants should adapt
FDA hears mixed views on third class of drugs
Pharmacists' organizations were out in force at a recent FDA hearing on the possibility of creating a third category of drugs that would be placed "behind-the-counter" and pharmacist-assisted.
GPHA to state governments: Increase access to generics
GPhA urges state governments to increase access to generics
ASHP to convene IV safety summit next spring
ASHP will hold a meeting with several other organizations to study how infusion-related errors can be eliminated.
Take Care Health Clinics debut at Walgreens in Nashville
Three Take Care Health Clinics open at Walgreens in Nashville